Gemcitabine for
Injection
Indications: Gemcitabine for injection is
typically utilized, in combination therapy or alone, for the
treatment of ovarian cancer, breast cancer, non-small cell lung
cancer, and pancreatic cancer. For indication, dosing and
other information, please refer to the manufacture package insert.
|
| |
| Manufacturer |
Product |
Size |
NDC |
PI |
MSDS |
|
Hospira |
Gemcitabine INJ |
200mg 38mg/mL
FTV |
00409-0183-01 |
PI |
MSDS |
|
Sagent |
Gemcitabine INJ |
200mg
Lyophilized
PreventIV
MeasuresSM
|
25021-0208-10 |
PI |
MSDS |
|
Accord |
Gemcitabine INJ |
200mg
lyophilized |
16729-0092-03 |
PI |
MSDS |
|
Caraco |
Gemcitabine INJ |
200mg
lyophilized |
47335-0153-40 |
PI |
MSDS |
|
Hospira |
Gemcitabine INJ |
1g 38mg/mL FTV |
00409-0181-01 |
PI |
MSDS |
|
Sagent |
Gemcitabine INJ |
1g Lyophilized
PreventIV
MeasuresSM
|
25021-0209-50 |
PI |
MSDS |
|
Accord |
Gemcitabine INJ |
1g lyophilized |
16729-0117-11 |
PI |
MSDS |
|
Caraco |
Gemcitabine INJ |
1g lyophilized |
47335-0154-40 |
PI |
MSDS |
|
Hospira |
Gemcitabine |
2g 38mg/mL FTV |
00409-0182-01 |
PI |
MSDS |
|
Hospira |
Gemcitabine INJ |
2g lyophilized |
00409-0187-01 |
PI |
MSDS |
|
Accord |
Gemcitabine INJ |
2g lyophilized |
16729-0118-38 |
PI |
MSDS |
|
| |
| Clinical
Data: For any questions
or for further information
related to Gemcitabine for
injection, clinical
pharmacology, additional
indications and usages,
contraindications, warnings,
precautions, adverse reactions,
dosage, administration and/or
storage of this product, please
contact
BDI Pharma or call 1-800-948-9834. |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |